ERBB2 and breast cancer: Among them, positive ESR1 and PGR status is crucial for the use of hormone therapy to treat BC, and HER2 status of 2 or 3 is an indication for targeted anti-Her2 therapeutic antibodies prescription in BC, e.g., trastuzumab [40].